YOLFTbeta
BioRestorative Therapies Inc

BioRestorative Therapies Inc

BRTX · NASDAQ · Healthcare / Biotechnology

1.49USD-0.01 (-0.67%)

Price History

Full chart

Market Stats

Previous Close1.50
Open1.56
Day Range1.45 – 1.56
52-Week Range2.45 – 34.60
Volume11.46K
Market Cap3.52M
P/E (TTM)0.00
Forward P/E0.00
EPS-21.20
Dividend Yield0.00%
Beta0.74
50-Day Avg4.13
200-Day Avg9.04

About

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Mika Grasso
  • Employees13
  • Headquarters40 Marcus Drive, Melville, NY, United States, 11747, USA
  • Websitehttps://www.biorestorative.com

Leadership

  • Mr. Mika GrassoInterim CEO & Director · b. 1998
  • Ms. Anna SkowronCFO & Treasurer · b. 1987
  • Ms. Crystal RomanoHead of Global Commercial Operations

Financials

Income Statement

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---15.59K1.68K416.00K628.91K36.35K81.00K111.00K130.00K77.00K46.00K119.80K145.80K401.00K359.70K
Growth (%)-----89.22%+24661.67%+51.18%-94.22%+122.80%+37.04%+17.12%-40.77%-40.26%+160.43%+21.70%+175.03%-10.30%
Cost of Revenue---1.31K208213.83K261.50K102259.26K0--205.21K120.54K165.74K28.07K23.84K
Gross Profit---14.28K1.47K202.16K367.41K36.25K-178.26K111.00K-77.00K46.00K119.80K145.80K372.93K335.86K
Gross Margin---91.62%87.62%48.60%58.42%99.72%-220.07%100.00%-100.00%100.00%100.00%100.00%93.00%93.37%
Operating Expense---5.59M4.75M5.12M7.54M7.83M8.20M7.76M-2.83M26.35M18.98M15.37M11.93M15.98M
Operating Income--2.07M-3.55M-5.57M-4.75M-4.92M-7.17M-7.80M-8.37M-7.65M-8.43M-2.75M-26.31M-18.86M-15.22M-11.56M-15.65M
Operating Margin----35746.05%-282873.21%-1183.31%-1140.12%-21447.55%-10338.62%-6889.78%-6486.16%-3574.12%-57191.03%-15745.83%-10439.49%-2881.59%-4350.05%
EBITDA--1.85M-3.38M-5.85M-4.65M-4.83M-7.11M-7.61M-8.10M-9.06M-9.29M-9.48M-42.40M-13.10M-14.97M-8.79M-14.03M
EBITDA Margin----37555.36%-276634.46%-1160.06%-1129.99%-20943.26%-9997.56%-8158.25%-7147.30%-12312.44%-92171.35%-10936.35%-10268.66%-2192.10%-3901.03%
Net Income--2.26M-4.07M-6.54M-5.75M-5.59M-7.92M-8.64M-9.44M-12.52M-14.65M-11.27M-44.30M-13.22M-10.42M-8.98M-14.24M
Net Income Margin----41931.63%-342332.98%-1343.19%-1259.87%-23755.44%-11660.07%-11277.30%-11267.61%-14639.85%-96311.51%-11036.97%-7145.20%-2239.25%-3959.40%
R&D-11.62K12.00K416.18K1.59M1.43M2.11M2.88M2.15M1.51M1.72M876.83K729.06K3.51M4.03M5.35M10.09M
R&D as % of Total Revenue---2669.70%94884.17%343.90%334.71%7931.68%2657.32%1363.20%1324.88%1138.74%1584.91%2932.68%2767.21%1333.84%2806.41%
Interest Expense024.16K260.01K591.81K371.28K285.27K603.03K763.94K1.09M3.22M5.14M1.64M1.82M11.65K---
Interest Expense % of Total Revenue---3796.35%22100.06%68.58%95.88%2101.35%1342.44%2902.50%3953.11%2130.06%3946.45%9.72%---

Balance Sheet

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.79M468.51K220.97K1.27M1.38M1.69M2.02M1.58M1.76M1.19M1.47M4.35M22.45M16.43M12.61M12.28M4.08M
Total Liabilities305.00K1.21M3.91M6.41M8.07M8.58M5.93M6.58M8.60M9.83M14.24M5.68M856.50K6.14M2.61M3.75M3.72M
Total Equity7.48M-744.22K-3.69M-5.14M-6.69M-6.89M-3.91M-5.00M-6.84M-8.64M-12.78M-1.33M21.60M10.29M10.00M8.53M356.74K
Cash-18.07K71.51K363201.10K91.80K166.56K31.82K451.68K117.52K1.66K3.06M21.03M1.71M884.38K547.89K1.51M
Total Debt-710.92K3.04M4.56M5.51M5.74M1.31M2.16M3.66M4.15M7.75M4.79M670.70K301.64K162.32K162.32K-
Net Debt-692.85K2.97M4.56M5.31M5.65M1.15M2.12M3.21M4.03M7.75M1.73M-20.36M-1.41M-722.06K-547.89K-1.51M

Cash Flow

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--729.22K-2.81M-3.18M-2.67M-3.23M-3.12M-5.00M-3.85M-5.10M-6.92M-1.96M-3.33M-5.91M-6.43M-8.23M-10.79M
Investing Cash Flow--48.78K14.23K-1.00M-11.16K-167.40K-483.07K-188.76K-3.62K-12.87K-35.63K-35.63K-30.66K-13.40M3.25M514.53K8.90M
Financing Cash Flow169.00K796.03K2.85M4.12M2.88M3.29M3.68M5.06M4.28M4.78M6.84M5.03M21.32M21.07M2.35M7.38M2.85M
Capital Expenditure112.00K48.78K17.77K1.00M11.16K168.38K483.07K188.76K3.62K12.87K35.63K35.63K30.66K440.22K171.04K106.19K116.07K
Free Cash Flow--778.00K-2.83M-4.19M-2.68M-3.40M-3.61M-5.19M-3.86M-5.12M-6.95M-1.96M-3.36M-6.35M-6.60M-8.34M-10.91M
Dividends Paid--------------569.07K623.80K270.57K
FCF to OCF-106.69%100.63%131.49%100.42%105.22%115.47%103.77%100.09%100.25%100.51%100.00%100.92%107.44%102.66%101.29%101.08%
Dividend Paid to FCF---------------8.62%-7.48%-2.48%

Earnings

Report DateJun 30, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Nov 14, 2017Mar 31, 2018Apr 2, 2018Aug 14, 2018Nov 13, 2018Mar 29, 2019May 15, 2019Aug 14, 2019Nov 13, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 29, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 30, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 27, 2023May 12, 2023Aug 11, 2023Nov 13, 2023Mar 18, 2024Jun 11, 2024Aug 13, 2024Nov 12, 2024Mar 31, 2025May 14, 2025Aug 12, 2025Nov 12, 2025Mar 26, 2026May 14, 2026Sep 29, 2026
EPS Estimate-0.00------------------------------------------4.99-0.54-0.63-0.55-1.45-1.35-1.26-1.56-0.68-0.69-0.51-0.56-0.35-0.55-0.32-0.41-0.38-0.34-0.303.00
EPS Actual-33199.72-2.03-2.36-1.93-1.01-2.58-2.50-2.16-2.40-2.05-1.52-1.54-1.88-1.65-1.17-0.81-0.93-1.00-0.64-0.57-1.02-0.69-0.56-0.43-0.45-0.56-0.51-0.37-0.37-0.39-0.33-0.53-0.39-0.35-0.28-0.24-0.23-0.01144.27-41.95-0.04-0.01-5.10-4.99-6.90-1.37-1.28-1.28-1.18-1.53-0.77-0.64-0.57-0.59-0.28-0.01-0.38-0.64-0.30-0.33-0.32-0.126.00
Surprise-------------------------------------------0.00%-1177.78%-117.46%-132.73%11.72%12.59%-21.43%50.64%5.88%17.39%-15.69%50.00%97.14%32.22%-100.00%26.83%13.16%5.88%60.00%100.00%
Timing----------------------------------------Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hours-

Key Statistics & Ratios

Market Cap3.52M
Enterprise Value-9.50M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales9.84
Price / Book1.17
EPS-21.20
Book Value2.38
Revenue (TTM)357.87K
Gross Profit (TTM)329.55K
EBITDA-14.01M
Profit Margin0.00%
Operating Margin-14612.57%
Return on Equity-241.14%
Return on Assets-118.81%
Shares Outstanding1.38M
Shares Float1.21M
Beta0.74
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 160.00
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
13.90%
Insiders
9.56%
Retail / Other
76.54%

Top Institutional Holders

  • Citadel Advisors Llc
    273.30K3.08%
  • Geode Capital Management, LLC
    223.08K2.51%
  • UBS Group AG
    99.83K1.12%
  • Wealth Alliance, LLC
    40.00K0.45%
  • Vanguard Fiduciary Trust Co
    39.45K0.44%
  • State Street Corp
    32.46K0.37%
  • Keystone Financial Group Inc
    28.60K0.32%
  • Advisor Group Holdings, Inc.
    2.00K0.02%
  • Tower Research Capital LLC
    1.46K0.02%
  • SBI Securities Co Ltd
    1990.00%
  • Bank of America Corp
    00.00%
  • TD Waterhouse Canada Inc
    30.00%
  • DRW Securities, LLC
    00.00%
  • Napier Financial, LLC
    00.00%
  • TWO SIGMA SECURITIES, LLC
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    127.22K1.43%
  • Fidelity Total Market Index
    13.40K0.15%
  • Fidelity Series Total Market Index
    8.56K0.10%

Stock Splits

  • Sep 8, 20261:20
  • Oct 27, 20211:4000
  • Jul 7, 20151:20
  • Apr 15, 20131:50